|The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111 …|
M Bond, G Rogers, J Peters, R Anderson, M Hoyle, A Miners, T Moxham, ...
NIHR Journals Library, 2012
|Temozolomide for high grade glioma|
MG Hart, R Garside, G Rogers, K Stein, R Grant
The Cochrane Library, 2013
|Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis|
JT Coon, G Rogers, P Hewson, D Wright, R Anderson, M Cramp, ...
NIHR Journals Library, 2007
|The harmful health effects of recreational ecstasy: a systematic review of observational evidence|
G Rogers, J Elston, R Garside, C Roome, R Taylor, P Younger, A Zawada, ...
Health Technology Assessment 13 (6), xii-338, 2009
|Chemotherapy wafers for high grade glioma|
MG Hart, R Garside, G Rogers, M Somerville, K Stein, R Grant
The Cochrane Library, 2011
|Surveillance of cirrhosis for hepatocellular carcinoma: a cost–utility analysis|
JT Coon, G Rogers, P Hewson, D Wright, R Anderson, S Jackson, ...
British journal of cancer 98 (7), 1166-1175, 2008
|Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment …|
J Shepherd, G Rogers, R Anderson, C Main, J Thomson-Coon, D Hartwell
Health Technology Assessment 12 (19), 1-360, 2008
|Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model|
C Hyde, J Peters, M Bond, G Rogers, M Hoyle, R Anderson, M Jeffreys, ...
Age and Ageing, 2012
|The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation|
R Garside, M Pitt, R Anderson, G Rogers, M Dyer, S Mealing, ...
NIHR Journals Library, 2007
|Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness|
JST Coon, Z Liu, M Hoyle, G Rogers, C Green, T Moxham, K Welch, ...
British journal of cancer 101 (2), 238-243, 2009
|Diagnosis and management of gallstone disease: summary of NICE guidance|
S Warttig, S Ward, G Rogers
British Medical Journal Publishing Group 349, g6241, 2014
|Dasatinib and nilotinib for imatinib-resistant or-intolerant chronic myeloid leukaemia: A systematic review and economic evaluation|
JT Coon, M Hoyle, M Pitt, G Rogers, T Moxham, Z Liu, K Stein
|Dasatinib and nilotinib for imatinib-resistant or-intolerant chronic myeloid leukaemia: a systematic review and economic evaluation|
G Rogers, M Hoyle, JT Coon, T Moxham, Z Liu, M Pitt, K Stein
Health Technology Assessment 16 (22), 1366-5278, 2012
|Patient self-assessment of hospital pain, mood and health-related quality of life in adults with sickle cell disease|
KA Anie, H Grocott, L White, M Dzingina, G Rogers, G Cho
BMJ open 2 (4), e001274, 2012
|Cost-effectiveness of dasatinib and nilotinib for imatinib-resistant or-intolerant chronic phase chronic myeloid leukemia|
M Hoyle, G Rogers, T Moxham, Z Liu, K Stein
Value in Health 14 (8), 1057-1067, 2011
|Parkinson’s disease: summary of updated NICE guidance|
G Rogers, D Davies, J Pink, P Cooper
Bmj 358, j1951, 2017
|Carmustine Implants for the Treatment of Newly Diagnosed High-Grade Gliomas: A Cost-Utility Analysis|
G Rogers, R Garside, S Mealing, M Pitt, R Anderson, M Dyer, K Stein, ...
PharmacoEconomics 26 (1), 33-44, 2008
|Spondyloarthritis: diagnosis and management: summary of NICE guidance|
K McAllister, N Goodson, L Warburton, G Rogers
BMJ 356, j839, 2017
|The clinical-and cost effectiveness of lenalidomide for multiple myeloma in people who have received at least one prior therapy: an evidence review of the submission from Celgene|
M Hoyle, G Rogers, R Garside, T Moxham, K Stein
Submission to NICE as part of STA program, 2008
|Assessment and referral after emergency treatment of a suspected anaphylactic episode: summary of NICE guidance.|
M Dzingina, H Stegenga, M Heath, D Jones, G Rogers, J Kleijnen, R Wolff, ...
BMJ (Clinical research ed.) 343, d7595, 2011